Remicade and Magnevist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Remicade and Magnevist together.

The phase IV clinical study analyzes what interactions people who take Remicade and Magnevist have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

4 people who take Remicade and Magnevist together, and have interactions are studied.


What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 188,112 Remicade users for its effectiveness, alternative drugs and more.

What is Magnevist?

Magnevist has active ingredients of gadopentetate dimeglumine. eHealthMe is studying from 10,497 Magnevist users for its effectiveness, alternative drugs and more.

Number of Remicade and Magnevist reports submitted per year:

Remicade and Magnevist drug interactions.

Common Remicade and Magnevist drug interactions by gender *:

female:

  1. Pruritus
  2. Urticaria
  3. Bone pain
  4. Burning sensation
  5. Chest discomfort
  6. Gait disturbance
  7. Joint contracture
  8. Joint range of motion decreased
  9. Joint swelling
  10. Muscle tightness

male:

  1. Abdominal pain
  2. Anxiety
  3. Fibrosis
  4. Gait disturbance
  5. General physical health deterioration
  6. Impaired healing
  7. Injury
  8. Joint contracture
  9. Mobility decreased
  10. Muscular weakness

Common Remicade and Magnevist drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pruritus
  2. Urticaria
  3. Burning sensation

40-49:

  1. Gait disturbance
  2. Joint contracture
  3. Anxiety
  4. Aphagia
  5. Arthralgia
  6. Constipation
  7. Deformity
  8. Disability
  9. Dry skin
  10. Emotional distress

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and Magnevist?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Remicade and Magnevist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Remicade interactions:

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnevist interactions:

Browse all interactions between Magnevist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on infliximab and gadopentetate dimeglumine (the active ingredients of Remicade and Magnevist, respectively), and Remicade and Magnevist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Remicade and Magnevist.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: